Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VV119 in Adults With Acute Schizophrenia
NCT07703956Phase 2Not yet recruiting
- Sponsor
- Vigonvita Life Sciences
- Start
- Jul 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of VV119 in schizophrenia, sponsored by Vigonvita Life Sciences. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
VV119
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT07703956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07703956.